20251107_MMIX_Laporan Informasi dan Fakta Material_31983586.pdf

kami menyampaikan apresiasi dan ucapan terima kasih atas kepercayaan, dukungan, serta kerja sama yang telah
diberikan selama proses penelaahan dan evaluasi berlangsung. Perseroan berkomitmen untuk: 1. Mematuhi seluruh
ketentuan dan peraturan perundang-undangan di bidang pasar modal, termasuk kewajiban keterbukaan informasi dan
pelaporan berkala kepada OJK dan BEI; 2. Menjaga transparansi, tata kelola perusahaan yang baik (Good Corporate
Governance), serta kepatuhan terhadap prinsip-prinsip keterbukaan; 3. Mengoptimalkan pemanfaatan dana hasil
pencatatan efek sesuai dengan rencana yang telah disampaikan dalam Perseroan; Memberikan nilai tambah bagi para
pemegang saham, investor, dan seluruh pemangku kepentingan.

Demikian untuk diketahui.


Hormat Kami,
PT Multi Medika Internasional Tbk




Eveline N.Susanto

Direktur Keuangan




PT Multi Medika Internasional Tbk
Jl. Peternakan III No.55B, Kapuk Cengkareng, Jakarta Barat 11720
Telepon : +62 21 2967-6078, Fax : +62 21 565 9458, www.multimed.co.id



 Nama Pengirim                      Eveline N.Susanto

 Jabatan                            Direktur Keuangan
 Tanggal dan Waktu                  07-11-2025 14:14

 Lampiran                           1. Suurat tanggapan penerbitan efek MMIX.pdf


                                    2. Surat Penerbitan Efek MMIX 2025.pdf


  Dokumen ini merupakan dokumen resmi PT Multi Medika Internasional Tbk yang tidak memerlukan tanda tangan
      karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. PT Multi Medika Internasional Tbk
                    bertanggung jawab penuh atas informasi yang tertera didalam dokumen ini.

Go To Indonesian Page

 Letter / Announcement No.            078/MMI-CORP/XI/2025

 Issuer Name                          PT Multi Medika Internasional Tbk

 Issuer Code                          MMIX

 Attachment                           2

 Subject                              Other Material Information or Facts That the Submission of Response to IDX
                                      Letter No.: No.: S-12453/BEI.PP1/10-2025 Regarding Approval of Securities
                                      Listing

The company hereby announce the Material Information or Facts Report as follows

 Name of Issuer or Public Company              PT Multi Medika Internasional Tbk

 Business Activities                           Perdagangan Besar Alat Laboratorium, Alat Farmasi dan Alat
                                               Kedokteran Untuk Manusia, dan Sewa Guna Usaha Tanpa

 Telephone                                     +62 21 2967-6078

 Faximile                                      +62 21 565 9458

 Email Address                                 corpsec@multimed.co.id


 Date of Event                                 07 November 2025

                                               Other Material Information or Facts That the Submission of
 Type of Material Information or Facts         Response to IDX Letter No.: No.: S-12453/BEI.PP1/10-2025
                                               Regarding Approval of Securities Listing
 Description of Material Information or        Referring to:
 Facts                                         a. OJK Regulation No. 31/POJK04/2015 concerning
                                               Disclosure of Material Information or Facts by Issuers or Public
                                               Companies, dated December 10, 2015, POJK NO. 31/2015
                                               b. OJK Regulation No. 17/POJK04/2020 concerning Material
                                               Transactions and Changes in Business Activities, dated April
                                               20, 2020, POJK 17/2020
                                               c. OJK Regulation No. 42/POJK04/2020 concerning Affiliated
                                               Transactions and Conflict of Interest Transactions, dated July
                                               2, 2020, POJK 42/2020
                                               d. Regulation No. IE, Attachment to the Decree of the Board of
                                               Directors of the Indonesia Stock Exchange No.
                                               Kep00015BEI012021 dated February 1, 2021, concerning
                                               Amendments to Regulation No. IE concerning Obligations to
                                               Submit Information, Regulation No. IE

                                               This Information Disclosure is issued in connection with the
                                               Bonus Share Distribution Plan derived from the Capitalization
                                               of Share Premium.
 Impact of event, material information or      nothing
 facts towards Issuers or Public
 Company’s operational activities, legal,
 financial condition, or going concern




Other Information

<pre id="tw-target-text" class="tw-data-text tw-text-large tw-ta" dir="ltr" tabindex="-1" role="text" data-
placeholder="Translation" data-ved="2ahUKEwiRxcKyvN-QAxWtyjgGHUR7KigQ3ewLegQIDBAV" aria-
label="Translated text: We express our appreciation and gratitude for the trust, support, and cooperation provided
throughout the review and evaluation process.
The Company is committed to:
1. Complying with all capital market laws and regulations, including information disclosure obligations and periodic
reporting to the Financial Services Authority (OJK) and the Indonesia Stock Exchange (IDX);

2. Maintaining transparency, good corporate governance, and adherence to the principles of transparency;
3. Optimizing the utilization of proceeds from the securities listing in accordance with the plans communicated
within the Company;
4. Providing added value to shareholders, investors, and all stakeholders.">We express our appreciation and
gratitude for the trust, support, and cooperation provided throughout the review and evaluation process.
The Company is committed to:
1. Complying with all capital market laws and regulations, including information disclosure obligations and periodic
reporting to the Financial Services Authority (OJK) and the Indonesia Stock Exchange (IDX);
2. Maintaining transparency, good corporate governance, and adherence to the principles of transparency;
3. Optimizing the utilization of proceeds from the securities listing in accordance with the plans communicated
within the Company;
4. Providing added value to shareholders, investors, and all stakeholders.

Thus to be informed accordingly.


Respectfully,
PT Multi Medika Internasional Tbk




Eveline N.Susanto

Direktur Keuangan




PT Multi Medika Internasional Tbk
Jl. Peternakan III No.55B, Kapuk Cengkareng, Jakarta Barat 11720
Phone : +62 21 2967-6078, Fax : +62 21 565 9458, www.multimed.co.id



Sender Name                           Eveline N.Susanto

Function                              Direktur Keuangan

Date and Time                         07-11-2025 14:14

Attachment                           1. Suurat tanggapan penerbitan efek MMIX.pdf


                                     2. Surat Penerbitan Efek MMIX 2025.pdf


     This is an official document of PT Multi Medika Internasional Tbk that does not require a signature as it was
   generated electronically by the electronic reporting system. PT Multi Medika Internasional Tbk is fully responsible
                                   for the information contained within this document.